APLN and prostate cancer: We previously reported that apelin blockade reduces prostate cancer metastasis in tumor xenograft mouse models 19, the PC-3 cells were implanted into the anterior prostates of nude mice, and after 7 weeks, apelin blockade suppressed tumor growth by approximately 80% and 34%, as measured by IVIS imaging and manual tumor weight measurements, respectively.